ArticleNPJ breast cancer2025

Prosigna Risk of Recurrence score and intrinsic subtypes are associated with adjuvant anthracycline chemotherapy benefit in high-risk breast cancer.

Maj-Britt Jensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.